Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 15. November 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 2006  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 40101  
   
Delaying thoracic radiotherapy does not compromise overall survival in extensive-stage small cell lung cancer after first-line systemic treatment: a multicenter real-world cohort study.
Clin Transl Radiat Oncol
Zheng L, Le X, Huang Y, Cheng Q, Ying Z, Ding Y, Ye R, Zhang F, Chen H, Wang E, Zhu L, Yan R, You G, Wang S, Sun X, Wang Y, Fang J, Xu Y, Zhou Z.
PMID: 43032292 [PubMed]


Complement in cancer-associated fibroblasts: sources, regulation and context dependence.
Front Immunol
Lei K.
PMID: 43032046 [PubMed - indexed for MEDLINE]


Periostin within the tumor microenvironment: molecular insights and immunomodulatory roles in cancer.
Front Immunol
Zhao Y, Yu Y, Li S, Xu L, Chen W, Lv J.
PMID: 43032026 [PubMed - indexed for MEDLINE]


Clinical and CT body-composition model for major pathological response to neoadjuvant tislelizumab, albumin-bound paclitaxel, and nedaplatin in esophageal squamous cell carcinoma.
Front Oncol
Xu H, Zheng W, Chen S, Wu S.
PMID: 43031628 [PubMed]


Artificial Intelligence-Assisted Endoscopic Assessment of Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer: From Residual Disease Detection to Active Surveillance and Surgical Decision-Making.
Diagnostics (Basel)
Tao Y, Zhao X, Zhao Y, Wang N, Wang M, Yao F.
PMID: 43028469 [PubMed]


Trends and Patterns in Gastrointestinal Cancer Burden in Asia, 1990-2023: Evidence from the Global Burden of Disease Study 2023.
Cancers (Basel)
Guo L, Zhu C, Yuan J, Cai L, Luan H, Chen H, Zheng Y, Liu Y.
PMID: 43026856 [PubMed]


A Literature-Derived Muscle Wasting-Related Prognostic Signature Identifies ZBTB7C as a Candidate Associated with Tumor-Related Skeletal Muscle Alterations in Esophageal Cancer.
Cancers (Basel)
Li Y, Xie C, Chen R, Ming Z, Huang H, Ding S.
PMID: 43026800 [PubMed]


Artificial Intelligence in Thoracic Surgical Oncology: Technical Foundations and Applications in Lung and Esophageal Cancer Surgery.
Cancers (Basel)
Cassidy R, Razzaq S, Howell A, Leiva-Juarez M, Schumacher L.
PMID: 43026760 [PubMed]


First-line treatment of gastric cancer: Five trials to watch.
Med
Narita Y, Muro K.
PMID: 43025398 [PubMed - indexed for MEDLINE]


A visual molecular classifier based on Bsu-T7 weighted linear isothermal amplification for precision cancer diagnosis.
Biosens Bioelectron
Lin Y, Li Y, Cui C, Geng A, Sun Y, Zhu Q, Zhang Z, Su G, Yu Y.
PMID: 43025095 [PubMed - as supplied by publisher]


Association of sex and age on outcomes of maintenance treatment in pati​ents with advanced esophagogastric adenocarcinoma: an exploratory analysis of the randomized AIO-YMO-0111-MATEO trial.
J Cancer Res Clin Oncol
Stocker G, Stelmach R, Lorenzen S, Ettrich T, Knödler M, Longo F, Chibaudel B, Greil R, Perwög M, Larcher-Steiner J, Held S, Lordick F, Haag GM.
PMID: 43024019 [PubMed - indexed for MEDLINE]


Multi-omics and pharmacological analyses identify DDX60 as a candidate EGCG-engaged target in esophageal squamous cell carcinoma.
Eur J Pharmacol
Zhu H, Ainiwa A, Zhang YH, Lv GH, Zhao LT, Abuduwaili A, Chen HY, Jing XL, Ma RY.
PMID: 43020306 [PubMed - as supplied by publisher]


Izalontamab Brengitecan in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma: The PANKU-Esophagus01 Randomized Clinical Trial.
JAMA
Lu Z, Huang Z, Meng X, Fan Y, Wu T, Pang Q, Wang F, Zhang Y, Gao S, Liu T, Zhou J, Fang Y, Li N, Li W, Cao G, Zhou S, Li N, Ye F, Ji Y, Zhang J, Cai X, Xiong J, Zhang M, Wan L, Gu Y, Luo H, Zhang X, Qu J, Yang W, Cao J, Zhu X, Chen J, Yi T, Gao Y, Huang J, Liu Z, Wang J, Ma F, Luo Y, Ma X, Fu J, Ding S, Liu Y, Xiao S, Zhu H, Zhu Y, Shen L, PANKU-Esophagus01 Investigators.
PMID: 43018949 [PubMed - as supplied by publisher]


Acute Hematemesis Leading to the Incidental Diagnosis of Esophageal Squamous Cell Carcinoma in an Adolescent: First Case Report From Pakistan.
Clin Case Rep
Hameed M, Mazhar Z, Abedeen ZU, Sohaib HU, Bashir H, Zainab HH, Ghani MZ, Rehman AU.
PMID: 43016893 [PubMed]


Association of trilaciclib use with hematologic outcomes during perioperative immunochemotherapy in resectable esophageal squamous cell carcinoma: a prospective observational cohort study.
Front Pharmacol
He C, Lin X, Xu H, Lin J, Li P, Wang W, Chen B, Lin R, Zhang S, Li H, Zhang X, Li Y, Huang Z, Xie R, Chen Z, Wu J, Huang C, Guo R, Gao H, Xie Z, Wu H.
PMID: 43016856 [PubMed]


Multi-omics integration identifies serum FTL as a novel diagnostic biomarker for esophageal squamous cell carcinoma.
Front Immunol
Chen WZ, Chen SL, Han RK, Wu XR, Liang JC, Wu MT, Sun GY, Chen H.
PMID: 43016823 [PubMed - indexed for MEDLINE]


Barriers and facilitators for implementing active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer in Dutch hospitals: a qualitative study.
BMJ Open
Gangaram Panday SSG, Kim Y, Ista E, Mostert B, Kranenburg L, van Lanschot JJB, Spaander MCW, Dekker JWT, Heisterkamp J, Nieuwenhuijzen GAP, Pierie JP, Rosman C, van Sandick JW, Lagarde SM, Wijnhoven BPL, SANO Study Group.
PMID: 43015016 [PubMed - in process]


Imaging-Based AI for Predicting Pathological Complete Response in Esophageal Cancer After Neoadjuvant Therapy: Systematic Review and Meta-Analysis.
J Med Internet Res
Li Z, Gao X, Zhou J, Wang L, Ren F.
PMID: 43013774 [PubMed - indexed for MEDLINE]


Pre-treatment serum bicarbonate predicts survival in patients with locally advanced esophageal squamous cell carcinoma undergoing definitive radiotherapy: a retrospective propensity score matching study.
BMC Cancer
Ji H, Zhang P, Wang Y, Su Y, Si H, Jia Y, Qiao X, Zhou Z.
PMID: 43009855 [PubMed - indexed for MEDLINE]


High tissue factor (CD142) expression identifies a poor-prognosis subgroup of esophageal and esophagogastric junction adenocarcinoma.
BMC Cancer
Bedau T, Zander T, Schlößer H, Büttner R, Bruns C, Quaas A.
PMID: 43009849 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 40101    Seite 1 von 2006  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1